西班牙多发性硬化症患者的睡眠障碍。

G.X. Zhang , W.T. Zhang , S.S. Gao , R.Z. Zhao , W.J. Yu , G. Izquierdo
{"title":"西班牙多发性硬化症患者的睡眠障碍。","authors":"G.X. Zhang ,&nbsp;W.T. Zhang ,&nbsp;S.S. Gao ,&nbsp;R.Z. Zhao ,&nbsp;W.J. Yu ,&nbsp;G. Izquierdo","doi":"10.1016/j.nrleng.2021.03.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>This study assesses the presence of sleep disturbances and their relationship with clinical and demographic variables in patients with MS, with a view to establishing correlations between the different variables and the frequency of sleep disturbances.</p></div><div><h3>Methods</h3><p>The Pittsburgh Sleep Quality Index (PSQI) was used to detect sleep disorders. We contacted patients treated at the MS unit and distributed a questionnaire (PSQI) to 221 patients, receiving 142 usable questionnaires between 8 and 30 September 2019.</p></div><div><h3>Results</h3><p>The prevalence of patients with sleep disturbances in our study was 74.7% (73.7% in women and 76.8% in men). Therefore, sleep disorders are pervasive in patients with MS, with 3 out of 4 patients experiencing them, a higher rate than that observed in the population without the disease. The frequency of sleep disorders gradually increased in line with age. In the 2 age groups analyzed, 44–54 years and 55–68 years, the proportion of moderate and severe sleep disorders was 42.8% and 53.9%, respectively. Moderate and severe sleep disturbances were observed in 27.5%, 44.7%, and 58.3% of patients with Expanded Disability Status Scale scores of 0–3, 3–6, and &gt;6, respectively.</p></div><div><h3>Conclusion</h3><p>Our results indicate that sleep disorders are more common in patients with MS than in other populations. Patients with secondary progressive forms of MS more frequently present sleep disturbances, while patients with primary progressive forms report them less frequently. Age and degree of disability were positively correlated with the prevalence and severity of sleep disorders in MS patients.</p></div>","PeriodicalId":94155,"journal":{"name":"Neurologia","volume":"39 1","pages":"Pages 29-35"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2173580823000676/pdfft?md5=d8a44992ddcc91170150fc94066131d1&pid=1-s2.0-S2173580823000676-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Sleep disorders in patients with multiple sclerosis in Spain\",\"authors\":\"G.X. Zhang ,&nbsp;W.T. Zhang ,&nbsp;S.S. Gao ,&nbsp;R.Z. Zhao ,&nbsp;W.J. Yu ,&nbsp;G. Izquierdo\",\"doi\":\"10.1016/j.nrleng.2021.03.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>This study assesses the presence of sleep disturbances and their relationship with clinical and demographic variables in patients with MS, with a view to establishing correlations between the different variables and the frequency of sleep disturbances.</p></div><div><h3>Methods</h3><p>The Pittsburgh Sleep Quality Index (PSQI) was used to detect sleep disorders. We contacted patients treated at the MS unit and distributed a questionnaire (PSQI) to 221 patients, receiving 142 usable questionnaires between 8 and 30 September 2019.</p></div><div><h3>Results</h3><p>The prevalence of patients with sleep disturbances in our study was 74.7% (73.7% in women and 76.8% in men). Therefore, sleep disorders are pervasive in patients with MS, with 3 out of 4 patients experiencing them, a higher rate than that observed in the population without the disease. The frequency of sleep disorders gradually increased in line with age. In the 2 age groups analyzed, 44–54 years and 55–68 years, the proportion of moderate and severe sleep disorders was 42.8% and 53.9%, respectively. Moderate and severe sleep disturbances were observed in 27.5%, 44.7%, and 58.3% of patients with Expanded Disability Status Scale scores of 0–3, 3–6, and &gt;6, respectively.</p></div><div><h3>Conclusion</h3><p>Our results indicate that sleep disorders are more common in patients with MS than in other populations. Patients with secondary progressive forms of MS more frequently present sleep disturbances, while patients with primary progressive forms report them less frequently. Age and degree of disability were positively correlated with the prevalence and severity of sleep disorders in MS patients.</p></div>\",\"PeriodicalId\":94155,\"journal\":{\"name\":\"Neurologia\",\"volume\":\"39 1\",\"pages\":\"Pages 29-35\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2173580823000676/pdfft?md5=d8a44992ddcc91170150fc94066131d1&pid=1-s2.0-S2173580823000676-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2173580823000676\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2173580823000676","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究评估多发性硬化症患者是否存在睡眠障碍及其与临床和人口统计学变量之间的关系:本研究评估多发性硬化症患者是否存在睡眠障碍及其与临床和人口统计学变量之间的关系,以期建立不同变量与睡眠障碍频率之间的相关性:方法:采用匹兹堡睡眠质量指数(PSQI)检测睡眠障碍。我们联系了在多发性硬化症科接受治疗的患者,并向221名患者发放了问卷(PSQI),在2019年9月8日至30日期间共收到142份可用问卷:在我们的研究中,睡眠障碍患者的患病率为74.7%(女性为73.7%,男性为76.8%)。因此,睡眠障碍在多发性硬化症患者中普遍存在,每4名患者中就有3名存在睡眠障碍,这一比例高于未患病人群。睡眠障碍的发生率随着年龄的增长而逐渐增加。在分析的 44-54 岁和 55-68 岁两个年龄组中,中度和重度睡眠障碍的比例分别为 42.8%和 53.9%。在残疾状况扩展量表评分为0-3分、3-6分和大于6分的患者中,分别有27.5%、44.7%和58.3%的患者出现中度和重度睡眠障碍:我们的研究结果表明,与其他人群相比,睡眠障碍在多发性硬化症患者中更为常见。继发性进展型多发性硬化症患者更常出现睡眠障碍,而原发性进展型多发性硬化症患者则较少出现睡眠障碍。年龄和残疾程度与多发性硬化症患者睡眠障碍的发生率和严重程度呈正相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Sleep disorders in patients with multiple sclerosis in Spain

Objective

This study assesses the presence of sleep disturbances and their relationship with clinical and demographic variables in patients with MS, with a view to establishing correlations between the different variables and the frequency of sleep disturbances.

Methods

The Pittsburgh Sleep Quality Index (PSQI) was used to detect sleep disorders. We contacted patients treated at the MS unit and distributed a questionnaire (PSQI) to 221 patients, receiving 142 usable questionnaires between 8 and 30 September 2019.

Results

The prevalence of patients with sleep disturbances in our study was 74.7% (73.7% in women and 76.8% in men). Therefore, sleep disorders are pervasive in patients with MS, with 3 out of 4 patients experiencing them, a higher rate than that observed in the population without the disease. The frequency of sleep disorders gradually increased in line with age. In the 2 age groups analyzed, 44–54 years and 55–68 years, the proportion of moderate and severe sleep disorders was 42.8% and 53.9%, respectively. Moderate and severe sleep disturbances were observed in 27.5%, 44.7%, and 58.3% of patients with Expanded Disability Status Scale scores of 0–3, 3–6, and >6, respectively.

Conclusion

Our results indicate that sleep disorders are more common in patients with MS than in other populations. Patients with secondary progressive forms of MS more frequently present sleep disturbances, while patients with primary progressive forms report them less frequently. Age and degree of disability were positively correlated with the prevalence and severity of sleep disorders in MS patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
53 weeks
期刊最新文献
Sporadic fatal insomnia: a rapidly progressive phenotype resembling progressive supranuclear palsy. Thrombosis with thrombocytopenia syndrome following adenovirus vector-based vaccines to prevent COVID-19: Epidemiology and clinical presentation in Spain. Incidence and prevalence of multiple sclerosis in Spain: a systematic review Functional outcomes of patients with NORSE and FIRES treated with immunotherapy: A systematic review Psychometric properties of the Spanish version of the Frontal Assessment Battery (FAB-E) and normative values in a representative adult population sample
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1